Andrew Adams

Co-Founder & General Partner



T (203) 717-1370



Andrew Adams,
Co-Founder & General Partner

Oak HC/FT Co-Founder & General Partner Andrew Adams has more than 20 years of experience as a venture capitalist investing in transformative companies and entrepreneurs.

In 2014, Andrew, along with Annie Lamont and Patricia Kemp, launched Oak HC/FT, a venture capital fund investing in early to growth stage tech-enabled companies shaping the future of healthcare information and financial services.

Prior to founding Oak HC/FT, Andrew served as a partner at Oak Investment Partners. He began his career as a financial analyst at Deutsche Banc Alex. Brown and went on to become a senior associate with Capital Resource Partners.

Andrew received his bachelor’s degree in history from Princeton University.

Andrew’s active investments are listed below.

Active Investments:

  • Independent Living Systems
  • Limeade
  • One Medical Group
  • Precision for Medicine Holdings
  • US HealthVest
  • xG Health Solutions

Prior Investments:

  • American Esoteric Laboratories (acquired by Sonic Healthcare Limited)
  • Argus Information & Advisory Services (acquired by Verisk Analytics)
  • Benefitfocus (NASDAQ: BNFT)
  • CareMedic Systems (acquired by Ingenix)
  • CLARiENT (NSDQ: CLRT; acquired by GE Healthcare)
  • Core Informatics (acquired by Thermo Fisher Scientific)
  • Health Dialog (acquired by British United Provident Association)
  • iHealth Technologies (merged with Connolly)
  • LDI Integrated Pharmacy Services (acquired by Diplomat Pharmacy)
  • Maestro Health (acquired by AXA Group)
  • NetSpend Corporation (NASDAQ: NTSP; acquired by TSYS)
  • PayFlex Systems (acquired by Aetna)
  • PharMEDium Healthcare (acquired by Clayton, Dubilier & Rice)
  • United BioSource (acquired by Medco Health Solutions)